Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Brigitta Miyamoto, M.D.

Concepts (14)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Brigitta Miyamoto's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Brigitta Miyamoto has written about over time.
Animals, 1 publications between 2011 and 2011, average publication date July 2011. Biotechnology, 1 publications between 2011 and 2011, average publication date July 2011. Clinical Trials as Topic, 1 publications between 2011 and 2011, average publication date July 2011. Drug Approval, 1 publications between 2011 and 2011, average publication date July 2011. Orphan Drug Production, 1 publications between 2011 and 2011, average publication date July 2011. Rare Diseases, 1 publications between 2011 and 2011, average publication date July 2011. United States, 1 publications between 2011 and 2011, average publication date July 2011. United States Food and Drug Administration, 1 publications between 2011 and 2011, average publication date July 2011. Humans, 2 publications between 2011 and 2022, average publication date October 2016. Adolescent, 1 publications between 2022 and 2022, average publication date January 2022. Child, 1 publications between 2022 and 2022, average publication date January 2022. Child Psychiatry, 1 publications between 2022 and 2022, average publication date January 2022. Mental Health, 1 publications between 2022 and 2022, average publication date January 2022. Pandemics, 1 publications between 2022 and 2022, average publication date January 2022.

To see the data from this visualization as text, click here.
Miyamoto's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (14)
Explore
_
Co-Authors (2)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.